Author

Fiona Lucas

Observed name: F Lucas

Institution: Imperial College London

Observed institutions: GlaxoSmithKline (United Kingdom), GlaxoSmithKline Research & Development Limited (United Kingdom), Imperial College London

ORCID: 0000-0003-3289-2018

Observed ORCID: 0000-0003-3289-2018

OpenAlex ID: A5102824280

Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study

2017 · Wendy Atkin, Kate Wooldrage, et al. · The Lancet Oncology · 252

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease

2015 · Kenneth Down, Augustin Amour, et al. · Journal of Medicinal Chemistry · 134

Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study

2019 · Wendy Atkin, Amanda J Cross, et al. · Health Technology Assessment · 129

The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization

2005 · Sharon Bingham, Paul J. Beswick, et al. · Journal of Pharmacology and Experimental Therapeutics · 63

Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors

2004 · Paul Beswick, Sharon Bingham, et al. · Bioorganic & Medicinal Chemistry Letters · 46

Characterization of selective Calcium-Release Activated Calcium channel blockers in mast cells and T-cells from human, rat, mouse and guinea-pig preparations

2013 · Louise V. Rice, Heather J. Bax, et al. · European Journal of Pharmacology · 44

The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations

2017 · Wendy Atkin, Amy Brenner, et al. · Health Technology Assessment · 38

Identification and optimisation of a novel series of pyrimidine based cyclooxygenase-2 (COX-2) inhibitors. Utilisation of a biotransformation approach

2009 · Paul J. Beswick, Andrew P. Blackaby, et al. · Bioorganic & Medicinal Chemistry Letters · 21

The Effect of Adenoma Surveillance on Colorectal Cancer Incidence: A Multicentre Cohort Study

2017 · Wendy S. Atkin, Amy Brenner, et al. · Gastroenterology

Rules applied for data analysis

2017 · Wendy Atkin, Amy Brenner, et al.

PWE-344 Retrospective cohort study to examine the frequency of follow-up for patients with intermediate grade colorectal adenomas (ia study)

2015 · A Brenner, J Martin, et al.

Works count: 11

Citation count: 727

H-index: 8

I10-index: 8